Evidence map›Paper›PMID 32479604›Full record

ArticleNeuro-oncology2020

Receptor discordance in breast cancer brain metastases: when knowledge is power.

Sarah Sammons, Amanda E D Van Swearingen, Carey K Anders

Abstract readComment
In one paragraph

Article in Neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Genomic and immune profiling of breast cancer brain metastases.Acta neuropathologica communications · 2025
    Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sarah SammonsDuke Cancer Institute, Division of Medical Oncology, Department of Medicine, Durham, North Carolina.
Amanda E D Van SwearingenDuke Cancer Institute, Division of Medical Oncology, Department of Medicine, Durham, North Carolina.
Carey K AndersDuke Cancer Institute, Division of Medical Oncology, Department of Medicine, Durham, North Carolina.

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
NCI NIH HHS P30 CA014236
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansLymphatic MetastasisErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID32479604
PMCPMC7594573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.